About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

SerpinE2: Essential Target to Fight Melanoma Metastasis

by Vaishali Gokulakrishnan on September 22, 2017 at 6:33 PM
Font : A-A+

SerpinE2: Essential Target to Fight Melanoma Metastasis

The identification of a slowly proliferating and highly invasive melanoma cell subpopulation, characterized by production of a protein associated with invasive behavior. The research was published in the journal Oncogene, which is a study conducted at The Wistar Institute.

The pattern of metastatic dissemination in advanced melanoma is unpredictable because of the biological and genetic heterogeneity that characterizes melanoma cells. Specifically, they differ in their proliferation rates, ability to invade other tissues and interaction with the surrounding microenvironment.

Advertisement


"Understanding the biological events that take place at distant sites from the primary tumor is crucial for preventing or slowing metastasis," said lead researcher Meenhard Herlyn, D.V.M., D.Sc., Caspar Wistar Professor in Melanoma Research and director of The Wistar Institute Melanoma Research Center. "Our new findings suggest that we need to adjust our treatment strategies for early disease and target individual, disseminating tumor cells that we are likely missing with the current diagnostic techniques."

Previous research in the Herlyn lab has shown the existence of a slowly proliferating population of melanoma cells that is required for tumor maintenance. In the new study, Herlyn and colleagues characterized the invasive properties of this slowly proliferating population, demonstrating its ability to leave the primary tumor and disseminate rapidly to distant sites.
Advertisement

The cells were tracked based on their ability to retain a fluorescent dye. Following fluorescence labeling of the whole cell population, the fluorescence intensity decreases by half at each cell division and gets diluted out and disappears in fast-dividing cells, whereas the signal is retained longer in dormant or slowly dividing cells. By utilizing this technique, the researchers were able to determine that the slowly proliferating melanoma cells have a highly invasive behavior in vivo.

After injection in immunocompromised mice, the fluorescence disappears rapidly from the primary tumor and emerges at distant sites. Importantly, some of the slowly proliferating cells retain the fluorescent label long after colonizing other tissues, indicating that they can remain dormant for long periods of time and regain proliferative capacity at a later stage, eventually leading to metastasis.

No correlation was found between the low proliferative, highly invasive state and the most common genetic alterations that cause melanoma, indicating that the slowly proliferating population is genetically heterogeneous.

However, through proteomic analysis, Herlyn and colleagues found that the slowly proliferating cells express higher levels of the protein SerpinE2, which has a pro-invasive role in other types of cancer. They also demonstrated that SerpinE2 is critical for melanoma invasion and its expression levels in melanoma patients correlate with tumor progression.

"SerpinE2 is expressed by melanoma cells and not by normal skin cells," said Michela Perego, Ph.D., an associates staff scientist at Wistar and first author of the study.

"Therefore, it may be a potential useful tool for early detection of isolated malignant cells that have left the primary tumor and colonized distant organs and possibly a novel target to prevent or limit melanoma dissemination."

"This concept may sound counterintuitive because we are used to the idea that cancer cells are highly proliferative," added Herlyn, also professor in Wistar's Molecular and Cellular Oncogenesis Program. "However, slowly proliferating melanoma cells are more aggressive and therefore the most dangerous ones."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Skin Cancer Ultra-Violet Radiation Melanoma 

Recommended Reading
Ipilimumab Combined With Local Treatments Improve Survival for Melanoma Patients
Local peripheral treatments are not used to cure patients with malignant melanoma; rather, they are ...
Routine Blood Test Improves Melanoma Disease Monitoring
New research represents a significant advance for melanoma patients, as the ability to identify ......
Is The Accuracy of Melanoma Diagnoses A Matter of Concern?
When interpreting melanocytic lesions, high levels of diagnostic disagreement were found among ......
Melanoma Response Predicted Through Mathematical Modeling
Novel approach offers better treatment schedule to improve outcomes, reduce toxicity....
Melanoma
Melanoma is a dangerous form of skin cancer caused largely due to exposure to the sun’s damaging UV ...
Skin Cancer
Skin cancer is an abnormal growth of skin cells. It can develop due to a continuous exposure to sun ...
Ultra-Violet Radiation
Ultraviolet radiations are electromagnetic radiations with wavelengths shorter than the shortest wav...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use